Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 265,921 | 277,149 | 269,850 | 261,176 | 248,142 |
| Cost of Goods | 48,880 | 52,626 | 51,457 | 47,627 | 43,886 |
| Gross Profit | 217,041 | 224,523 | 218,393 | 213,549 | 204,256 |
| Operating Expenses | 159,927 | 159,099 | 153,847 | 149,610 | 144,706 |
| Operating Income | 57,994 | 66,050 | 65,003 | 64,566 | 60,436 |
| Other Income | 80,709 | 3,772 | 9,759 | -6,689 | 6,835 |
| Pre-tax Income | 138,703 | 69,822 | 74,762 | 57,877 | 67,271 |
| Income Tax | 32,570 | 15,268 | 14,437 | 12,125 | 10,318 |
| Net Income Continuous | 106,133 | 54,554 | 60,325 | 45,752 | 56,953 |
| Net Income | $106,133 | $54,554 | $60,325 | $45,752 | $56,953 |
| EPS Basic Total Ops | 2.34 | 1.20 | 1.33 | 1.01 | 1.25 |
| EPS Basic Continuous Ops | 2.34 | 1.20 | 1.33 | 1.01 | 1.25 |
| EPS Diluted Total Ops | 2.32 | 1.19 | 1.33 | 1.00 | 1.24 |
| EPS Diluted Continuous Ops | 2.32 | 1.19 | 1.32 | 1.00 | 1.24 |
| EPS Diluted Before Non-Recurring Items | 1.30 | 1.25 | 1.16 | 1.13 | 1.03 |
| EBITDA(a) | $64,718 | $72,670 | $72,293 | $71,492 | $67,402 |